0

Eliprodil

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP119431253
CAS119431-25-3
Structure
MDL NumberMFCD00866651
Molecular Weight347.85
InChI KeyGGUSQTSTQSHJAH-UHFFFAOYSA-N
Description≥98% (HPLC), powder
SolubilityDMSO: 5 mg/mL, clear; H2O: insoluble
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

Block of P-type Ca2+ Channels by the NMDA Receptor Antagonist Eliprodil in Acutely Dissociated Rat Purkinje Cells

B Biton, P Granger, H Depoortere, B Scatton, P Avenet

Eur J Pharmacol. 1995 Dec 27;294(1):91-100.

PMID: 8788420

1

Motor Actions of Eliprodil in the Normal and Monoamine-Depleted Mouse: A Role in the Treatment of Parkinson's Disease?

S Brooks, S Kaur, B S Starr, M S Starr

J Neural Transm (Vienna). 1996;103(6):737-48.

PMID: 8836935

1

R- And L-type Ca2+ Channels Are Insensitive to Eliprodil in Rat Cultured Cerebellar Granule Neurons

B Biton, D Godet, P Granger, P Avenet

Eur J Pharmacol. 1997 Apr 4;323(2-3):277-81.

PMID: 9128850

1

Stereoselective Determination of Unchanged and Glucuroconjugated Eliprodil, a New Anti-Ischaemic Drug, in Human Plasma and Urine by Precolumn Derivatization and Column-Switching High-Performance Liquid Chromatography With Fluorescence Detection

B Malavasi, M Ripamonti, A Rouchouse, V Ascalone

J Chromatogr A. 1996 Apr 5;729(1-2):323-33.

PMID: 9004957

1

The Effects of Ifenprodil and Eliprodil on Voltage-Dependent Ca2+ Channels and in Gerbil Global Cerebral Ischaemia

C P Bath, L N Farrell, J Gilmore, M A Ward, C A Hicks, M J O'Neill, D Bleakman

Eur J Pharmacol. 1996 Mar 28;299(1-3):103-12.

PMID: 8901012

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode